EP 1178993 A1 20020213 - THIAZOLODERIATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
Title (en)
THIAZOLODERIATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
Title (de)
THIAZOLODERIVATE UND DIESE ENTHALTENDE PHARMAZEUTISCHE ZUBEREITUNGEN
Title (fr)
DERIVES DE THIAZOLE ET COMPOSITIONS PHARMACEUTIQUES CONTENANT CES DERIVES
Publication
Application
Priority
- EP 0004279 W 20000511
- GB 9911863 A 19990521
Abstract (en)
[origin: WO0071549A1] Compounds of formula (I); processes to prepare such compounds; compositions containing such compounds and their use in the treatment of depression, anxiety, psychoses (for examples schizophrenia), tardive dyskinesia, obesity, drug addiction, drug abuse, cognitive disorders, Alzheimer's disease, cerebral ischaemia, obsessive-compulsive behaviour, panic attacks, social phobias, eating disorders such as bulimia, anorexia, snacking and binge eating, non-insulin dependent diabetes mellitus, hyperglycaemia, hyperlipidaemia, stress, and their use in the treatment and/or prophylaxis of seizures, neurological disorders such as epilepsy and/or conditions in which there is neurological damage such as stroke, brain trauma, cerebral ischaemia, head injuries and haemorrhage and as an aid to smoking cessation; are described.
IPC 1-7
IPC 8 full level
A61K 31/429 (2006.01); A61K 31/519 (2006.01); A61P 1/04 (2006.01); A61P 1/14 (2006.01); A61P 1/16 (2006.01); A61P 3/00 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61P 9/02 (2006.01); C07D 487/04 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 11/16 (2006.01); A61P 13/02 (2006.01); A61P 15/00 (2006.01); A61P 15/10 (2006.01); A61P 19/02 (2006.01); A61P 19/06 (2006.01); A61P 25/00 (2006.01); A61P 25/08 (2006.01); A61P 25/14 (2006.01); A61P 25/18 (2006.01); A61P 25/20 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); A61P 25/30 (2006.01); A61P 25/34 (2006.01); A61P 31/18 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07D 471/04 (2006.01); C07D 513/04 (2006.01)
CPC (source: EP KR)
A61P 1/04 (2018.01 - EP); A61P 1/14 (2018.01 - EP); A61P 1/16 (2018.01 - EP); A61P 3/00 (2018.01 - EP); A61P 3/04 (2018.01 - EP); A61P 3/06 (2018.01 - EP); A61P 3/10 (2018.01 - EP); A61P 9/02 (2018.01 - EP); A61P 9/10 (2018.01 - EP); A61P 9/12 (2018.01 - EP); A61P 11/16 (2018.01 - EP); A61P 13/02 (2018.01 - EP); A61P 15/00 (2018.01 - EP); A61P 15/10 (2018.01 - EP); A61P 19/02 (2018.01 - EP); A61P 19/06 (2018.01 - EP); A61P 25/00 (2018.01 - EP); A61P 25/08 (2018.01 - EP); A61P 25/14 (2018.01 - EP); A61P 25/18 (2018.01 - EP); A61P 25/20 (2018.01 - EP); A61P 25/22 (2018.01 - EP); A61P 25/24 (2018.01 - EP); A61P 25/28 (2018.01 - EP); A61P 25/30 (2018.01 - EP); A61P 25/34 (2018.01 - EP); A61P 31/18 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07D 513/04 (2013.01 - EP KR)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0071549 A1 20001130; AU 5065700 A 20001212; BG 106227 A 20020830; BR 0010827 A 20020604; CA 2374926 A1 20001130; CN 1361783 A 20020731; CZ 20014171 A3 20020612; EP 1178993 A1 20020213; GB 9911863 D0 19990721; HU P0201376 A2 20020828; IL 146540 A0 20020725; JP 2003500410 A 20030107; KR 20020033626 A 20020507; MX PA01011895 A 20040319; NO 20015667 D0 20011120; NO 20015667 L 20020121; PL 352282 A1 20030811; SK 16852001 A3 20020509; TR 200200164 T2 20020422; ZA 200110022 B 20030528
DOCDB simple family (application)
EP 0004279 W 20000511; AU 5065700 A 20000511; BG 10622701 A 20011217; BR 0010827 A 20000511; CA 2374926 A 20000511; CN 00810653 A 20000511; CZ 20014171 A 20000511; EP 00935009 A 20000511; GB 9911863 A 19990521; HU P0201376 A 20000511; IL 14654000 A 20000511; JP 2000619805 A 20000511; KR 20017014892 A 20011121; MX PA01011895 A 20000511; NO 20015667 A 20011120; PL 35228200 A 20000511; SK 16852001 A 20000511; TR 200200164 T 20000511; ZA 200110022 A 20011205